Coronavirus Disease 2019 (COVID-19) and the Incidence of Obstetric and Gynecologic Emergency Department Visits in an Integrated Health Care System

Coronavirus Disease 2019 (COVID-19) and the Incidence of Obstetric and Gynecologic Emergency Department Visits in an Integrated Health Care System
复制标题

DOI:
10.1097/aog.0000000000004331
复制
发表时间:
2021-04-01
影响因子:
7.2
通讯作者:
Zaritsky, Eve
Zaritsky, Eve
中科院分区:
医学2区
文献类型:
--
作者:
Abel, Mary Kathryn;Alavi, Mubarika X.;Zaritsky, Eve

文献摘要

被引文献

相似文献

方法我们检查了在COVID-19大流行之前和期间因产科或妇科问题就诊于Kaiser Permanente北方加州艾德的18岁或以上女性患者的人口统计学和临床特征以及发病率(每10万人-周风险)。妇产科疾病包括阴道出血、盆腔或外阴阴道感染、盆腔疼痛和其他(表1)。2019冠状病毒病大流行期间(大流行早期[2020年3月4日至5月19日]和大流行后期[2020年5月20日至9月1日])的发病率与大流行前期间(2020年1月1日至3月3日)的发病率进行了比较。2020年3月4日是北方加利福尼亚州首例报告的COVID-19死亡病例的日期,2020年5月20日是凯撒医疗机构北方加州恢复择期手术病例的日期。此外,为确保时间差异并非由于季节性波动所致,我们将二零二零年的疫情前、疫情初期及疫情后期与二零一九年的相应期间进行比较。将不同时间段的差异与总体发病率比值进行比较,并按关键患者特征和诊断进行分层。2我们的研究得到了凯泽永久北方加州研究决定办公室的批准。
METHODSWe examined demographic and clinical characteristics and incidence rates (per 100,000 person-weeks at risk) of female patients aged 18 years or older presenting to a Kaiser Permanente Northern California ED with obstetric or gynecologic concerns before and during the COVID-19 pandemic. Obstetric and gynecologic conditions included vaginal bleeding, pelvic or vulvovaginal infection, pelvic pain, and other (Table 1). Incidence rates for the COVID-19 pandemic period (both early pandemic [March 4–May 19, 2020] and late pandemic [May 20–September 1, 2020]) were compared with those in the prepandemic period (January 1–March 3, 2020). March 4, 2020 was the date of the first reported death from COVID-19 in Northern California, and May 20, 2020 was the date that Kaiser Permanente Northern California resumed elective surgery cases. Additionally, to ensure that temporal differences were not due to seasonal fluctuations, we compared the prepandemic, early-pandemic, and late-pandemic periods in 2020 with the corresponding periods in 2019. Differences among time periods were compared with incidence rate ratios overall and stratified by key patient characteristics and diagnoses. 2 Our study was approved by the Kaiser Permanente Northern California Research Determination Office.